Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SHA/600161 stock hub

SHA/600161 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHA/600161is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

28.4B

Shanghai Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHA/600161

In the news

Latest news · SHA/600161

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E30.5

P25 17.1P50 24.2P75 37.8

Trailing P/E29.5

P25 23.5P50 41.3P75 83.2

ROE8.8

P25 -0.9P50 4.1P75 8.8

ROIC9.4

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHA/600161 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

236

Groups with data

Currency

CNY

Showing 236 of 236 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	5,205
Employees Change	-93%
Employees Change Percent	-1.76
Enterprise value	CNY 30.2B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Isin	CNE000000WF9
Last refreshed	2026-05-10
Market cap	CNY 28.4B
Price	CNY 14.35
Price currency	CNY
Rev Per Employee	1,151,195.69x
Sector	Healthcare
Sic	2836
Symbol	sha/600161
Website	https://www.tiantanbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.43%
EV Earnings	31.06x
EV/EBIT	19.14x
EV/EBITDA	15.01x
EV/FCF	-1,291.34x
EV/Sales	5.04x
FCF yield	-0.08%
Forward P/E	30.54x
P/B ratio	1.83x
P/E ratio	29.5x
P/S ratio	4.74x
PE Ratio10 Y	51.86x
PE Ratio3 Y	33.99x
PE Ratio5 Y	40.22x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	26.35%
EBITDA Margin	33.29%
Gross margin	41.19%
Gross Profit	CNY 2.5B
Gross Profit Growth	-23.03%
Gross Profit Growth Q	-34.67%
Gross Profit Growth3 Y	1.75%
Gross Profit Growth5 Y	7.17%
Net Income	CNY 972.6M
Net Income Growth	-34.14%
Net Income Growth Q	-48.45%
Net Income Growth Years	0%
Net Income Growth3 Y	-1.5%
Net Income Growth5 Y	8.1%
Pretax Margin	27.36%
Profit Margin	16.23%
Profit Per Employee	CNY 186,851
Profitable Years	31
ROA	6
Roa5y	7.86
ROCE	10.04
ROE	8.77
Roe5y	12.45
ROIC	9.43
Roic5y	16.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	6.67%
Cagr15y	6.96%
Cagr1y	-24.57%
Cagr20y	10.59%
Cagr3y	-13.42%
Cagr5y	-8.58%
Div CAGR10	8.43%
Div CAGR3	81.71%
Div CAGR5	29.2%
EPS Growth	-34.11
EPS Growth Q	-50
EPS Growth Years	0
EPS Growth3 Y	-1.22
EPS Growth5 Y	6.21
OCF Growth	1,167.02%
OCF Growth10 Y	2.87%
OCF Growth3 Y	-25.96%
OCF Growth5 Y	1.83%
Revenue Growth	-2.22x
Revenue Growth Q	-13.36x
Revenue Growth Years	10x
Revenue Growth3 Y	7.31x
Revenue Growth5 Y	11.13x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.36
Assets	CNY 16.7B
Cash	CNY 1.9B
Current Assets	CNY 8.4B
Current Liabilities	CNY 947.3M
Debt	CNY 91.8M
Debt EBITDA	CNY 0.05
Debt Equity	CNY 0.01
Debt FCF	CNY -3.92
Equity	CNY 15.5B
Interest Coverage	215.2
Liabilities	CNY 1.2B
Long Term Assets	CNY 8.3B
Long Term Liabilities	CNY 231.2M
Net Cash	CNY 1.8B
Net Cash By Market Cap	CNY 6.34
Net Cash Growth	-16.34%
Net Debt EBITDA	CNY -0.9
Net Debt Equity	CNY -0.12
Tangible Book Value	CNY 10.4B
Tangible Book Value Per Share	CNY 4.97
WACC	5.31

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.82
Inventory Turnover	0.87
Net Working Capital	CNY 5.5B
Quick ratio	4.4
Working Capital	CNY 7.4B
Working Capital Turnover	CNY 0.84

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.04%
Dividend Growth	0%
Dividend Growth Years	2%
Dividend per share	CNY 0.2
Dividend Years	9
Dividend Yield	1.39%
Ex Div Date	2025-09-25
Last Dividend	CNY 0.15
Payout Frequency	Annual
Payout Ratio	50.83%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	90.76%
1Y total return	-24.55%
200-day SMA	17.68
3Y total return	-35.1%
50-day SMA	15.31
50-day SMA vs 200-day SMA	50under200
5Y total return	-36.15%
All Time High	37.15
All Time High Change	-61.37%
All Time High Date	2020-08-04
All Time Low	0.71
All Time Low Change	1,927.7%
All Time Low Date	2005-07-12
ATR	0.26
Beta	0.19
Beta1y	0.25
Beta2y	0.21
Ch YTD	-12.18
High	14.43
High52	22.08
High52 Date	2025-08-04
High52ch	-35.01%
Low	14.1
Low52	14.04
Low52 Date	2026-05-07
Low52ch	2.21%
Ma50ch	-6.25%
Price vs 200-day SMA	-18.82%
RSI	37.67
RSI Monthly	29.61
RSI Weekly	23.1
Sharpe ratio	-2.13x
Sortino ratio	-2.54
Total Return	1.43%
Tr YTD	-12.18
Tr15y	174.34%
Tr1m	-2.78%
Tr1w	1.13%
Tr3m	-13.19%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 1.6B
Operating Income Growth	-34.14
Operating Income Growth Q	-45.93
Operating Income Growth3 Y	1.25
Operating Income Growth5 Y	7.87
Operating margin	26.35

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	930,800,226%
Net Borrowing	316,655,589
Shares Insiders	2.8%
Shares Institutions	13.17%
Shares Out	1,977,371,446
Shares Qo Q	7.97%
Shares Yo Y	-0.04%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY -23.4M
Average Volume	9,692,606.95x
Bv Per Share	5.65
CAPEX	CNY -648.3M
Ch10y	82.52
Ch15y	160.7
Ch1m	-2.78
Ch1w	1.13
Ch1y	-25.53
Ch20y	585
Ch3m	-13.19
Ch3y	-36.39
Ch5y	-37.85
Ch6m	-22.1
Change	1.49%
Change From Open	1.56
Close	14.14
Days Gap	-0.07
Depreciation Amortization	415,777,226
Dollar Volume	158,013,475.2
Earnings Date	2026-04-30
EBIT	CNY 1.6B
EBITDA	CNY 2B
EPS	CNY 0.49
F Score	4
FCF	CNY -23.4M
FCF EV Yield	-0.08x
FCF Per Share	CNY -0.01
Financing CF	-389,211,926
Fiscal Year End	December
Founded	1,966
Goodwill	572,146,931
Graham Number	7.86753
Graham Upside	-45.17
Income Tax	CNY 308M
Investing CF	-176,974,934
Is Primary Listing	1
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Last Split Date	2024-06-20
Last Split Type	Forward
Lynch Fair Value	CNY 3.94
Lynch Upside	-72.54
Ma150	16.86
Ma150ch	-14.9%
Ma20	14.75
Ma20ch	-2.71%
Net CF	58,647,054
Next Earnings Date	2026-08-26
Open	14.13
P OCF Ratio	45.41
Payment Date	2025-09-25
Position In Range	75.76
Ppne	5,904,897,435
Price Date	2026-05-08
Price EBITDA	CNY 14.23
Ptbv Ratio	2.72
Relative Volume	1.15x
Revenue	5,991,973,544x
Tax By Revenue	5.14x
Tax Rate	18.78%
Tr20y	648.45%
Tr6m	-22.1%
Volume	11,011,392

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHA/600161 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.4%

$0.20 annual per share

Payout ratio

+50.8%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+29.2%

2 consecutive years of growth

Total shareholder yield

+1.4%

Next ex-dividend date: 2025-09-25

Performance

SHA/600161 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHA/600161?

Insider, institutional, and short-interest positioning.

Institutional ownership

+13.2%

Share of float held by funds and institutions

Insider ownership

+2.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.0%

Negative means the company is buying back shares.

Technical

SHA/600161 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

37.7

Neutral momentum band

Price vs 200-day MA

-18.8%

50/200-day relationship not available

Beta (5Y)

0.19

Less volatile than the market

Sharpe ratio

-2.13

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHA/600161

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/600161 stock rating?

sha/600161 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/600161 analysis?

The full report lives at /stocks/sha/600161/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/600161?

The latest report frames sha/600161 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/600161 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.